Global Intravenous (IV) Solutions Market Research Report 2023

Publisher Name :
Date: 06-Feb-2023
No. of pages: 89
Inquire Before Buying

Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.

Highlights

The global Intravenous (IV) Solutions market was valued at US$ 11660 million in 2022 and is anticipated to reach US$ 15800 million by 2029, witnessing a CAGR of 5.2% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Global Intravenous Solutions key players include Baxter, Kelun Group, Fresenius Kabi, etc. Global top three manufacturers hold a share over 35%.

Asia-Pacific is the largest market, with a share over 45%, followed by Europe, and North America, both have a share over 40 percent.

In terms of product, Crystalloids is the largest segment, with a share over 77%. And in terms of application, the largest application is Basic IV Solutions, followed by Nutrient Infusion Solution, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Intravenous (IV) Solutions, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravenous (IV) Solutions.

The Intravenous (IV) Solutions market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Intravenous (IV) Solutions market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Intravenous (IV) Solutions companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

By Company

- ICU Medical Inc. (U.S.)

- B. Braun Melsungen AG (Germany)

- Fresenius Kabi AG (Germany)

- Baxter (U.S.)

- Amanta Healthcare (India)

- Terumo Medical Corporation (Tokyo)

- Grifols S.A. (Spain)

Segment by Type

- Peripheral Parenteral Nutrition

- Total Parenteral Nutrition

Segment by Application

- Hospital & Clinics

- Ambulatory

- Home Care

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Intravenous (IV) Solutions companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Global Intravenous (IV) Solutions Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Intravenous (IV) Solutions Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Peripheral Parenteral Nutrition
1.2.3 Total Parenteral Nutrition
1.3 Market by Application
1.3.1 Global Intravenous (IV) Solutions Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital & Clinics
1.3.3 Ambulatory
1.3.4 Home Care
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Intravenous (IV) Solutions Market Perspective (2018-2029)
2.2 Intravenous (IV) Solutions Growth Trends by Region
2.2.1 Global Intravenous (IV) Solutions Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Intravenous (IV) Solutions Historic Market Size by Region (2018-2023)
2.2.3 Intravenous (IV) Solutions Forecasted Market Size by Region (2024-2029)
2.3 Intravenous (IV) Solutions Market Dynamics
2.3.1 Intravenous (IV) Solutions Industry Trends
2.3.2 Intravenous (IV) Solutions Market Drivers
2.3.3 Intravenous (IV) Solutions Market Challenges
2.3.4 Intravenous (IV) Solutions Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Intravenous (IV) Solutions Players by Revenue
3.1.1 Global Top Intravenous (IV) Solutions Players by Revenue (2018-2023)
3.1.2 Global Intravenous (IV) Solutions Revenue Market Share by Players (2018-2023)
3.2 Global Intravenous (IV) Solutions Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Intravenous (IV) Solutions Revenue
3.4 Global Intravenous (IV) Solutions Market Concentration Ratio
3.4.1 Global Intravenous (IV) Solutions Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Intravenous (IV) Solutions Revenue in 2022
3.5 Intravenous (IV) Solutions Key Players Head office and Area Served
3.6 Key Players Intravenous (IV) Solutions Product Solution and Service
3.7 Date of Enter into Intravenous (IV) Solutions Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Intravenous (IV) Solutions Breakdown Data by Type
4.1 Global Intravenous (IV) Solutions Historic Market Size by Type (2018-2023)
4.2 Global Intravenous (IV) Solutions Forecasted Market Size by Type (2024-2029)
5 Intravenous (IV) Solutions Breakdown Data by Application
5.1 Global Intravenous (IV) Solutions Historic Market Size by Application (2018-2023)
5.2 Global Intravenous (IV) Solutions Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Intravenous (IV) Solutions Market Size (2018-2029)
6.2 North America Intravenous (IV) Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Intravenous (IV) Solutions Market Size by Country (2018-2023)
6.4 North America Intravenous (IV) Solutions Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Intravenous (IV) Solutions Market Size (2018-2029)
7.2 Europe Intravenous (IV) Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Intravenous (IV) Solutions Market Size by Country (2018-2023)
7.4 Europe Intravenous (IV) Solutions Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Intravenous (IV) Solutions Market Size (2018-2029)
8.2 Asia-Pacific Intravenous (IV) Solutions Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Intravenous (IV) Solutions Market Size by Region (2018-2023)
8.4 Asia-Pacific Intravenous (IV) Solutions Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Intravenous (IV) Solutions Market Size (2018-2029)
9.2 Latin America Intravenous (IV) Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Intravenous (IV) Solutions Market Size by Country (2018-2023)
9.4 Latin America Intravenous (IV) Solutions Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Intravenous (IV) Solutions Market Size (2018-2029)
10.2 Middle East & Africa Intravenous (IV) Solutions Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Intravenous (IV) Solutions Market Size by Country (2018-2023)
10.4 Middle East & Africa Intravenous (IV) Solutions Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ICU Medical Inc. (U.S.)
11.1.1 ICU Medical Inc. (U.S.) Company Detail
11.1.2 ICU Medical Inc. (U.S.) Business Overview
11.1.3 ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Introduction
11.1.4 ICU Medical Inc. (U.S.) Revenue in Intravenous (IV) Solutions Business (2018-2023)
11.1.5 ICU Medical Inc. (U.S.) Recent Development
11.2 B. Braun Melsungen AG (Germany)
11.2.1 B. Braun Melsungen AG (Germany) Company Detail
11.2.2 B. Braun Melsungen AG (Germany) Business Overview
11.2.3 B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Introduction
11.2.4 B. Braun Melsungen AG (Germany) Revenue in Intravenous (IV) Solutions Business (2018-2023)
11.2.5 B. Braun Melsungen AG (Germany) Recent Development
11.3 Fresenius Kabi AG (Germany)
11.3.1 Fresenius Kabi AG (Germany) Company Detail
11.3.2 Fresenius Kabi AG (Germany) Business Overview
11.3.3 Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Introduction
11.3.4 Fresenius Kabi AG (Germany) Revenue in Intravenous (IV) Solutions Business (2018-2023)
11.3.5 Fresenius Kabi AG (Germany) Recent Development
11.4 Baxter (U.S.)
11.4.1 Baxter (U.S.) Company Detail
11.4.2 Baxter (U.S.) Business Overview
11.4.3 Baxter (U.S.) Intravenous (IV) Solutions Introduction
11.4.4 Baxter (U.S.) Revenue in Intravenous (IV) Solutions Business (2018-2023)
11.4.5 Baxter (U.S.) Recent Development
11.5 Amanta Healthcare (India)
11.5.1 Amanta Healthcare (India) Company Detail
11.5.2 Amanta Healthcare (India) Business Overview
11.5.3 Amanta Healthcare (India) Intravenous (IV) Solutions Introduction
11.5.4 Amanta Healthcare (India) Revenue in Intravenous (IV) Solutions Business (2018-2023)
11.5.5 Amanta Healthcare (India) Recent Development
11.6 Terumo Medical Corporation (Tokyo)
11.6.1 Terumo Medical Corporation (Tokyo) Company Detail
11.6.2 Terumo Medical Corporation (Tokyo) Business Overview
11.6.3 Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Introduction
11.6.4 Terumo Medical Corporation (Tokyo) Revenue in Intravenous (IV) Solutions Business (2018-2023)
11.6.5 Terumo Medical Corporation (Tokyo) Recent Development
11.7 Grifols S.A. (Spain)
11.7.1 Grifols S.A. (Spain) Company Detail
11.7.2 Grifols S.A. (Spain) Business Overview
11.7.3 Grifols S.A. (Spain) Intravenous (IV) Solutions Introduction
11.7.4 Grifols S.A. (Spain) Revenue in Intravenous (IV) Solutions Business (2018-2023)
11.7.5 Grifols S.A. (Spain) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Intravenous (IV) Solutions Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Peripheral Parenteral Nutrition
Table 3. Key Players of Total Parenteral Nutrition
Table 4. Global Intravenous (IV) Solutions Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Intravenous (IV) Solutions Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Intravenous (IV) Solutions Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Intravenous (IV) Solutions Market Share by Region (2018-2023)
Table 8. Global Intravenous (IV) Solutions Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Intravenous (IV) Solutions Market Share by Region (2024-2029)
Table 10. Intravenous (IV) Solutions Market Trends
Table 11. Intravenous (IV) Solutions Market Drivers
Table 12. Intravenous (IV) Solutions Market Challenges
Table 13. Intravenous (IV) Solutions Market Restraints
Table 14. Global Intravenous (IV) Solutions Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Intravenous (IV) Solutions Market Share by Players (2018-2023)
Table 16. Global Top Intravenous (IV) Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous (IV) Solutions as of 2022)
Table 17. Ranking of Global Top Intravenous (IV) Solutions Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Intravenous (IV) Solutions Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Intravenous (IV) Solutions Product Solution and Service
Table 21. Date of Enter into Intravenous (IV) Solutions Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Intravenous (IV) Solutions Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Intravenous (IV) Solutions Revenue Market Share by Type (2018-2023)
Table 25. Global Intravenous (IV) Solutions Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Intravenous (IV) Solutions Revenue Market Share by Type (2024-2029)
Table 27. Global Intravenous (IV) Solutions Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Intravenous (IV) Solutions Revenue Market Share by Application (2018-2023)
Table 29. Global Intravenous (IV) Solutions Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Intravenous (IV) Solutions Revenue Market Share by Application (2024-2029)
Table 31. North America Intravenous (IV) Solutions Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Intravenous (IV) Solutions Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Intravenous (IV) Solutions Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Intravenous (IV) Solutions Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Intravenous (IV) Solutions Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Intravenous (IV) Solutions Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Intravenous (IV) Solutions Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Intravenous (IV) Solutions Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Intravenous (IV) Solutions Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Intravenous (IV) Solutions Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Intravenous (IV) Solutions Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Intravenous (IV) Solutions Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Intravenous (IV) Solutions Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Intravenous (IV) Solutions Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Intravenous (IV) Solutions Market Size by Country (2024-2029) & (US$ Million)
Table 46. ICU Medical Inc. (U.S.) Company Detail
Table 47. ICU Medical Inc. (U.S.) Business Overview
Table 48. ICU Medical Inc. (U.S.) Intravenous (IV) Solutions Product
Table 49. ICU Medical Inc. (U.S.) Revenue in Intravenous (IV) Solutions Business (2018-2023) & (US$ Million)
Table 50. ICU Medical Inc. (U.S.) Recent Development
Table 51. B. Braun Melsungen AG (Germany) Company Detail
Table 52. B. Braun Melsungen AG (Germany) Business Overview
Table 53. B. Braun Melsungen AG (Germany) Intravenous (IV) Solutions Product
Table 54. B. Braun Melsungen AG (Germany) Revenue in Intravenous (IV) Solutions Business (2018-2023) & (US$ Million)
Table 55. B. Braun Melsungen AG (Germany) Recent Development
Table 56. Fresenius Kabi AG (Germany) Company Detail
Table 57. Fresenius Kabi AG (Germany) Business Overview
Table 58. Fresenius Kabi AG (Germany) Intravenous (IV) Solutions Product
Table 59. Fresenius Kabi AG (Germany) Revenue in Intravenous (IV) Solutions Business (2018-2023) & (US$ Million)
Table 60. Fresenius Kabi AG (Germany) Recent Development
Table 61. Baxter (U.S.) Company Detail
Table 62. Baxter (U.S.) Business Overview
Table 63. Baxter (U.S.) Intravenous (IV) Solutions Product
Table 64. Baxter (U.S.) Revenue in Intravenous (IV) Solutions Business (2018-2023) & (US$ Million)
Table 65. Baxter (U.S.) Recent Development
Table 66. Amanta Healthcare (India) Company Detail
Table 67. Amanta Healthcare (India) Business Overview
Table 68. Amanta Healthcare (India) Intravenous (IV) Solutions Product
Table 69. Amanta Healthcare (India) Revenue in Intravenous (IV) Solutions Business (2018-2023) & (US$ Million)
Table 70. Amanta Healthcare (India) Recent Development
Table 71. Terumo Medical Corporation (Tokyo) Company Detail
Table 72. Terumo Medical Corporation (Tokyo) Business Overview
Table 73. Terumo Medical Corporation (Tokyo) Intravenous (IV) Solutions Product
Table 74. Terumo Medical Corporation (Tokyo) Revenue in Intravenous (IV) Solutions Business (2018-2023) & (US$ Million)
Table 75. Terumo Medical Corporation (Tokyo) Recent Development
Table 76. Grifols S.A. (Spain) Company Detail
Table 77. Grifols S.A. (Spain) Business Overview
Table 78. Grifols S.A. (Spain) Intravenous (IV) Solutions Product
Table 79. Grifols S.A. (Spain) Revenue in Intravenous (IV) Solutions Business (2018-2023) & (US$ Million)
Table 80. Grifols S.A. (Spain) Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Intravenous (IV) Solutions Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Intravenous (IV) Solutions Market Share by Type: 2022 VS 2029
Figure 3. Peripheral Parenteral Nutrition Features
Figure 4. Total Parenteral Nutrition Features
Figure 5. Global Intravenous (IV) Solutions Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Intravenous (IV) Solutions Market Share by Application: 2022 VS 2029
Figure 7. Hospital & Clinics Case Studies
Figure 8. Ambulatory Case Studies
Figure 9. Home Care Case Studies
Figure 10. Intravenous (IV) Solutions Report Years Considered
Figure 11. Global Intravenous (IV) Solutions Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Intravenous (IV) Solutions Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Intravenous (IV) Solutions Market Share by Region: 2022 VS 2029
Figure 14. Global Intravenous (IV) Solutions Market Share by Players in 2022
Figure 15. Global Top Intravenous (IV) Solutions Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous (IV) Solutions as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Intravenous (IV) Solutions Revenue in 2022
Figure 17. North America Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Intravenous (IV) Solutions Market Share by Country (2018-2029)
Figure 19. United States Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Intravenous (IV) Solutions Market Share by Country (2018-2029)
Figure 23. Germany Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Intravenous (IV) Solutions Market Share by Region (2018-2029)
Figure 31. China Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Intravenous (IV) Solutions Market Share by Country (2018-2029)
Figure 39. Mexico Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Intravenous (IV) Solutions Market Share by Country (2018-2029)
Figure 43. Turkey Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Intravenous (IV) Solutions Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. ICU Medical Inc. (U.S.) Revenue Growth Rate in Intravenous (IV) Solutions Business (2018-2023)
Figure 46. B. Braun Melsungen AG (Germany) Revenue Growth Rate in Intravenous (IV) Solutions Business (2018-2023)
Figure 47. Fresenius Kabi AG (Germany) Revenue Growth Rate in Intravenous (IV) Solutions Business (2018-2023)
Figure 48. Baxter (U.S.) Revenue Growth Rate in Intravenous (IV) Solutions Business (2018-2023)
Figure 49. Amanta Healthcare (India) Revenue Growth Rate in Intravenous (IV) Solutions Business (2018-2023)
Figure 50. Terumo Medical Corporation (Tokyo) Revenue Growth Rate in Intravenous (IV) Solutions Business (2018-2023)
Figure 51. Grifols S.A. (Spain) Revenue Growth Rate in Intravenous (IV) Solutions Business (2018-2023)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs